Inscrição na biblioteca: Guest
International Journal of Medicinal Mushrooms

Publicou 12 edições por ano

ISSN Imprimir: 1521-9437

ISSN On-line: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Medicinal Mushroom, Grifola gargal (Agaricomycetes), Lowers Triglyceride in Animal Models of Obesity and Diabetes and in Adults with Prediabetes

Volume 22, Edição 1, 2020, pp. 79-91
DOI: 10.1615/IntJMedMushrooms.2019033285
Get accessGet access

RESUMO

Grifola gargal is a medicinal mushroom with biological effects, such as antiatherogenic activity, and is used as a treatment for various chronic inflammatory diseases. The aim of this study is to investigate the antidiabetic and antiobesity effects of a low-molecular weight hot water extract from G. gargal (GGL) against diabetes type 2. In a human clinical trial, 10 subjects with prediabetes consumed 9.2 g of GGL daily for 4 weeks. The significant beneficial health effects observed were decreases in triglyceride levels. This is the first report of these results in humans. Moreover, in animal experiments, we investigated the influence of administered feed with 2% (w/w) GGL for 42 days by using KK-Ay and ob/ob mice as animal models of obesity and diabetes. Results showed that GGL reduces blood glucose and triglyceride levels and adipose tissue. GGL (2.0 mg/mL) significantly suppressed the expression of the cytokine interleukin-6 in 3T3-L1 cells compared with control cells. Thus, the results indicate that G. gargal may be used as a safe and healthy medicinal food to prevent and improve diabetes- and obesity-related metabolic syndrome.

Referências
  1. Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol. 2015;763:64-74.

  2. Narayanaswami V, Dwoskin LP. Obesity: current and potential pharmacotherapeutics and targets. Pharmacol Ther. 2017;170:116-47.

  3. Fukuda S, Hirata A, Nishizawa H, Nagao H, Kashine S, Kimura T, Inoue K, Fujishima Y, Yamaoka M, Kozawa J, Kitamura T, Yasuda T, Maeda N, Imagawa A, Funahashi T, Shimomura I. Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation. Cardiovasc Diabetol. 2015;14:1-8.

  4. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;535918.

  5. Casha SW, Beresforda SAA, Henderson JA, McTiernan A, Xiao L, Wang CY, Patrick DL. Dietary and physical activity behaviors related to obesity specific quality of life and work productivity: baseline results from a worksite trial. Br J Nutr. 2012;108(6):1134-42.

  6. World Health Organization. Obesity and overweight. 18 October 2017. Available from: http://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 26 May 2018.

  7. Deng R. Review of the hypoglycemic effects of five commonly used herbal food supplements. Recent Pat Food Nutr Agric. 2012;4(1):50-60.

  8. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H. Discovery and resupply of pharmacologically active plant derived natural products: a review. Biotechnol Adv. 2015;33(8): 1582-1614.

  9. Chi Q, Wang G, Sheng Y, Xu W, Shi P, Zhao C, Huang K. Ethanolic extract of the golden oyster mushroom, Pleurotus citrinopileatus (Agaricomycetes), alleviates metabolic syndrome in diet-induced obese mice. Int J Med Mushrooms. 2017;19(11):1001-8.

  10. Chien RC, Yang YC, Lai EI, Mau JL. Anti-inflammation and lipogenic inhibition of Taiwanofungus salmonea mycelium and Grifola frondosa fruiting body. Int J Med Mushrooms. 2017;19(7):629-40.

  11. Lo H-Ch, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms. 2011;13(5):401-26.

  12. Wasser SP. Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities: a review. Int J Med Mushrooms. 2017;19(4):279-317.

  13. Chang ST, Wasser SP. Current and future research trends in agricultural and biomedical applications of medicinal mushrooms and mushroom products (review). Int J Med Mushrooms. 2018;20(12):1121-33.

  14. Postemsky PD, Palermo AM, Curvetto NR. Protective effects of new medicinal mushroom, Grifola gargal Singer (higher Basidiomycetes), on induced DNA damage in somatic cells of Drosophila melanogaster. Int J Med Mushrooms. 2011;13(6):583-94.

  15. Postemsky P, Curvetto N. Enhancement of wheat grain antioxidant activity by solid state fermentation with Grifola spp. Int J Med Food. 2014;17(5):543-49.

  16. Postemsky PD, Curvetto NR. Submerged culture of Grifola gargal and G. sordulenta (higher Basidiomycetes) from Argentina as a source of mycelia with antioxidant activity. Int J Med Mushrooms. 2015;17(1):65-76.

  17. Harada E, D'Alessandro-Gabazza CN, Toda M, Morizono T, Totoki T, Yasuma T, Nishihama K, Kobayashi T, Sumiya T, Kawagishi H, Gabazza EC. The medicinal mushroom, Grifola gargal, ameliorates allergic bronchial asthma. Int J Med Food. 2018;21(2):136-45.

  18. Harada E, Morizono T, Sumiya T, Megro S. Production of Andean-Patagonic edible mushroom Grifola gargal on wood-based substrates. Mycoscience. 2015;56(6):616-21.

  19. Ito T, Kato M, Tsuchida H, Harada E, Niwa T, Osawa T. Ergothioneine as an anti-oxidant/anti-inflammatory component in several edible mushrooms. Food Sci Tech Res. 2011;17:103-10.

  20. Harada E, Nagatomi F, Kijidani Y, Meguro S, Kammera T. Utilization of soba-shochu distillery waste for production of benzaldehyde and ergothioneine from liquid culture of the edible basidiomycete Grifola gargal. Mushroom Sci Biotechnol. 2014;21(4):165-71.

  21. Asahi T, Wu X, Shimoda H, Hisaka S, Harada E, Kanno T, Nakamura Y, Kato Y, Osawa T. A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Biosci Biotechnol Biochem. 2016;80(2):313-17.

  22. Wu J, Choi JH, Yoshida M, Hirai H, Harada E, Masuda K, Koyama T, Yazawa K, Noguchi K, Nagasawa K, Kawagishi H. Osteoclast-forming suppressing compounds, gargalols A, B, and C, from the edible mushroom Grifola gargal. Tetrahedron. 2011;67(35):6576-81.

  23. Harada E, D'Alessandro-Gabazza CN, Toda M, Morizono T, Chelakkot-Govindalayathil A-L, Roeen Z, Urawa M, Yasuma T, Yano Y, Sumiya T, Gabazza EC. Amelioration of atherosclerosis by the new medicinal mushroom Grifola gargal Singer. J Med Food. 2015;18(8):872-81.

  24. Harada E, Morizono T, Sumiya T, Kawagishi H. Effect of the medicinal mushroom, Grifola gargal (Agaricomycetes), on bone turnover markers and serum lipids in middle-aged and elderly Japanese women. Int J Med Mushrooms. 2016;18(1):1-7.

  25. Yoshioka Y, Harada E, Ge D, Imai K, Katsuzaki H, Mishima T, Gabazza EC, Ashida H. Adenosine isolated from Grifola gargal promotes glucose uptake via PI3K and AMPK signalling pathways in skeletal muscle cells. J Funct Foods. 2017;33:268-77.

  26. Harada E, Morizono T, Saito M. Blood glucose-reducing and fat-reducing effects of a novel medicinal mushroom, Grifola gargal (Agaricomycetes). Int J Med Mushrooms. 2017;19(12):1071-81.

  27. Alberts P, Ronquist-Nii Y, Larsson C, Klingstrom G, Engblom L, Edling N, Lidell V, Berg I, Edlund P-O, Ashkzari M, Sahaf N, Norling S, Berggren V, Bergdahl K, Forsgren M, Abrahmsen L. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations. Horm Metab Res. 2005;37(7):402-7.

  28. Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem. 1980;255:4745-50.

  29. World Health Organization. Diabetes. 15 November 2017. Available from: http://www.who.int/en/news-room/fact-sheets/detail/diabetes. Accessed 28 May 2018.

  30. Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, Pang G, Cho KY, Song CH. White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res. 2010;30(1):49-56.

  31. Reza MA, Hossain MA, Damte D, Jo WS, Hsu WH, Park SC. Hypolipidemic and hepatic steatosis preventing activities of the wood ear medicinal mushroom Auricularia auricula-judae (higher Basidiomycetes) ethanol extract in vivo and in vitro. Int J Med Mushrooms. 2015;17(8):723-34.

  32. Choi HN, Jang YH, Kim MJ, Seo MJ, Kang BW, Jeong YK, Kim JI. Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice. Nutr Res Pract. 2014;8(2):172-76.

  33. Seng CK, Abdullah N, Aminudin N. Lipid-modulating effect of black lingzhi medicinal mushroom, Amauroderma rugosum (Agaricomycetes), on oleate-induced human hepatocellular liver carcinoma cells. Int J Med Mushrooms. 2017;19(12):1101-11.

  34. Miyazawa N, Yoshimoto H, Kurihara S, Hamaya T, Eguchi F. Improvement of diet-induced obesity by ingestion of mushroom chitosan prepared from Flammulina velutipes. J Oleo Sci. 2018;67(2):245-54.

  35. Maschio BH, Gentil BC, Caetano ELA, Rodrigues LS, Laurino LF, Spim SRV, Jozala AF, Dos Santos CA, Grotto D, Gerenutti M. Characterization of the effects of the shiitake culinary-medicinal mushroom, Lentinus edodes (Agaricomycetes), on severe gestational diabetes mellitus in rats. Int J Med Mushrooms. 2017;19(11):991-1000.

  36. Zhang J, Zhao X, Zhao LQ, Zhao J, Qi Z, Wang LA. A primary study of the antioxidant, hypoglycemic, hypolipidemic, and antitumor activities of ethanol extract of brown slimecap mushroom, Chroogomphus rutilus (Agaricomycetes). Int J Med Mushrooms. 2017;19(10):905-13.

  37. Choi JH, Kim DW, Kim S, Kim SJ. In vitro antioxidant and in vivo hypolipidemic effects of the king oyster culinary-medicinal mushroom, Pleurotus eryngii var. ferulae DDL01 (Agaricomycetes), in rats with high-fat diet-induced fatty liver and hyperlipidemia. Int J Med Mushrooms. 2017;19(2):107-19.

  38. Paravamsivam P, Heng CK, Malek SN, Sabaratnam V, M RR, Kuppusamy UR. Giant oyster mushroom Pleurotus giganteus (Agaricomycetes) enhances adipocyte differentiation and glucose uptake via activation of PPARy and glucose transporters 1 and 4 in 3T3-L1 cells. Int J Med Mushrooms. 2016;18(9):821-31.

  39. Kahles F, Liberman A, Halim C, Rau M, Mollmann J, Mertens RW, Ruckbeil M, Diepolder I, Walla B, Diebold S, Burgmaier M, Lebherz C, Marx N, Lehrke M. The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE/mice by blocking monocyte/macrophage activation. Mol Metab. 2018;14:150-57.

  40. Mori K, Ouchi K, Hirasawa N. The anti-inflammatory effects of lion's mane culinary-medicinal mushroom, Hericium erinaceus (higher Basidiomycetes) in a coculture system of 3T3-L1 adipocytes and RAW264 macrophages. Int J Med Mushrooms. 2015;17(7):609-18.

  41. Niwa T, Yokoyama S, Ito T, Osawa T. Reduction of leptin secretion by soy isoflavonoids in murine adipocytes in vitro. Phytochem Lett. 2010;3:122-25.

  42. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003;278(46):45777-84.

  43. Chien RC, Lin LM, Chang YH, Lin YC, Wu PH, Asatiani MD, Wasser SG, Krakhmalnyi M, Agbarya A, Wasser SP, Mau JL. Anti-inflammation properties of fruiting bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms. Int J Med Mushrooms. 2016;18(11):999-1009.

CITADO POR
  1. Chowdhury Pritha, Paul Santanu, The Potential Role of Mushrooms in The Prevention and Treatment of Diabetes: A Review, Journal of Biologically Active Products from Nature, 10, 5, 2020. Crossref

  2. Ji Xiuyu, Liu Xinli, Zhu Deqiang, Xu Zhenshang, Chu Yaqi, Zhang Song, Grifola Frondosa Polysaccharides affects gut microbiota and lipid profiles depended on the molecular weight in mice, 2021 International Conference on Information Technology and Biomedical Engineering (ICITBE), 2021. Crossref

  3. Mustafa Faheem, Chopra Hitesh, Baig Atif Amin, Avula Satya Kumar, Kumari Sony, Mohanta Tapan Kumar, Saravanan Muthupandian, Mishra Awdhesh Kumar, Sharma Nanaocha, Mohanta Yugal Kishore, Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI, Journal of Fungi, 8, 2, 2022. Crossref

2729 Visualizações do artigo 56 downloads de artigos Métricas
2729 VISUALIZAÇÕES 56 TRANSFERÊNCIAS 3 Crossref CITAÇÕES Google
Scholar
CITAÇÕES

Artigos com conteúdo semelhante:

Hypoglycemic and Hypolipidemic Effects of the Cracked-Cap Medicinal Mushroom Phellinus rimosus (Higher Basidiomycetes) in Streptozotocin-Induced Diabetic Rats International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 6
Thekkuttuparambil Ananthanarayanan Ajith, Kainoor Krishnankutty Janardhanan, Kuttikkadan A. Rony
Blood Glucose–Reducing and Fat-Reducing Effects of a Novel Medicinal Mushroom, Grifola gargal (Agaricomycetes) International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 12
Toshihiro Morizono, Masayoshi Saito, Etsuko Harada
Renoprotective Effects of Shout Camphor Medicinal Mushroom (Taiwanofungus camphorates, Basidiomycetes) Mycelia on Several Media in Mice with Chronic Kidney Disease International Journal of Medicinal Mushrooms, Vol.18, 2016, issue 12
Shu-Chi Wang, Alexandru Mihai Grumezescu, Yu-Mei Lin, Hsin-Yi Su, Cing-Yan Jhang, Chih-Hui Yang, Keng-Shiang Huang, Jiun-Hua Chou, Ruo-Yun Chung, Wei-Ting Wang
The Medicinal Cracked-Cap Polypore Mushroom Phellinus rimosus (Higher Basidiomycetes) Attenuates Alloxan-Induced Hyperglycemia and Oxidative Stress in Rats International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 3
Thekkuttuparambil Ananthanarayanan Ajith, Kainoor Krishnankutty Janardhanan, Kuttikkadan A. Rony, John Mathew
Protective Role of Naringenin Against Doxorubicin-Induced Cardiotoxicity in a Rat Model: Histopathology and mRNA Expression Profile Studies Journal of Environmental Pathology, Toxicology and Oncology, Vol.33, 2014, issue 4
Kumaresan Ganesan, Murugesan Ramachandran, Swathika Subburaman
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain